“george-scangos” Archives

in
Entry Author Date Location
Vir Advances Antibodies Against COVID-19, CEO Leads BIO’s Coronavirus Outreach 04/02/20 National
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More 10/11/19 San Francisco
Biogen’s Ehlers Leaving for Apple Tree, Steps Into Limelight as CEO 10/01/19 New York
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs 09/03/19 San Francisco
Biogen, Taking Its Crisis “Seriously,” Keeps Focus on Neuroscience 04/24/19 Boston
Adieu to Adu: Biogen’s Big Alzheimer’s Bet Flops, Shares Routed 03/21/19 Boston
Decibel Hauls in $55M to Bring Multiple Hearing Drugs to the Clinic 06/19/18 Boston
Arch’s Bob Nelsen on Big Biotech and Why Pharma Should Be Very Afraid 05/15/18 National
Scangos Heats Up Xconomy’s What’s Hot in Bay Area Biotech Lineup 11/02/17 San Francisco
Vir Biotech Vies for Global Approach to Tackling Infectious Disease 10/18/17 San Francisco
Biogen, Opening Bottlenecks, Sees Spine Drug Sales, Shares Rise 07/25/17 Boston
Alzheimer’s Drug Pipeline Analysis: Have We Hit Peak Amyloid? 06/21/17 National
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Better Together, or Apart? Biogen, Bioverativ Head Down Separate Paths 02/01/17 Boston
Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More 01/13/17 National
Scangos Surfaces to Lead New Infectious Disease Startup, Vir Biotech 01/06/17 San Francisco
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
Biogen Promotes Vounatsos to CEO, Capping Scangos’s 6-Year Run 12/19/16 Boston
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
With Biogen at a Crossroads, CEO Scangos to Step Down 07/21/16 Boston
Biogen’s Nerve Repair Drug Fails MS Study, Shares Fall 06/07/16 Boston
East Coast Biotech Roundup: Homology, Biogen, Intellia & More 05/05/16 Boston
Sharpening Neuro Focus, Biogen to Spin Out Hemophilia Biz 05/03/16 Boston
Ready Or Not: Next Alzheimer’s Drugs Might Strain Health Systems 04/19/16 National
East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More 02/11/16 New York
Biogen’s Scangos on Pricing, Deals, Hemophilia, Alzheimer’s & More 02/09/16 Boston
Biogen to Cut 400 Jobs in Massachusetts in Big Restructuring 10/21/15 Boston
At Exelixis, Morrissey Dreams Of Getting the Band Back Together 06/01/15 San Francisco
Exelixis Axes 70% of Workforce as Cancer Drug Flops, Shares Routed 09/02/14 San Francisco
Page 1 of 3 next page »